Navigation Links
US Oncology Research Affiliated Physicians to Present at 2011 ASCO Annual Meeting
Date:5/26/2011

rthwestGuru Sonpavde, MD, Texas OncologyYunfei Wang, Lina Asmar, PhD, US Oncology Research


  • Association of rash with improved outcomes by the addition of cetuximab (C) to second-line mitoxantrone plus prednisone (MP) for progressive mCRPC after docetaxel-based chemotherapy.Nicholas Vogelzang, MD, Comprehensive Cancer Centers of NevadaPaul Conkling, MD, Virginia Oncology AssociatesManuel Modiano, MD, Arizona Oncology Associates


  • An open-label, multicenter, randomized Phase Ib/II study of eribulin mesylate administered in combination with gemcitabine plus cisplatin versus gemcitabine plus cisplatin alone as first line therapy for locally advanced or metastatic bladder cancer.Marcus Neubauer, MD, Jody S. Garey, PharmD, Greg Nelson, Debra Patt, MD, Tom Cartwright, MD, Russ Hoverman, MD, Leslie T. Busby, MD, Barry Brooks, MD, Mark Sitarik, MD, Mike Kolodziej, MD, Roger Anderson Dr PH, Roy Beveridge, MD; on behalf of the US Oncology Pathways Task Force and Clinical Content Development Team


  • Bevacizumab therapy in advanced non-small cell lung cancer (NSCLC):  outcomes from a community oncology network.Mark Fleming, MD, Virginia Oncology AssociatesJohn Burke, MD, Rocky Mountain Cancer CentersJohn R. Caton, MD, Willamette Valley Cancer Institute and Research CenterGuru Sonpavde, MD, Texas Oncology


  • Ability of serum alkaline phosphatase (ALP) changes to complement PSA changes and predict survival in men with metastatic castration-resistant prostate cancer (mCRPC) receiving docetaxel and prednisone (DP).Aimee L. Ginsburg, PharmD, Debra M. Patt MD, Jennifer Flinn, Janet L. Espirito, PharmD, Marcus A. Neubauer, MD, J. Russell Hoverman, MD, PhD, Thomas H. Cartwright, MD, Leslie T. Busby, MD, Barry Don Brooks, MD, Michael A. Kolodziej, MD, Mark A. Sitarik, MD; on behalf of the US Oncology Pathways Task Force and Clinical Content Development T
    '/>"/>


  • SOURCE US Oncology, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
    2. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
    3. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
    4. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
    5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
    6. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
    7. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
    8. Pharsight Uses FDA Disease Model to Support Oncology Drug Development
    9. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
    10. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
    11. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/18/2014)... 2014 Just days before the government of ... contain the spread of Ebola, World Vision will begin a ... thanks to private donations. McKesson, the largest healthcare ... through its affiliate McKesson Medical-Surgical donated four million pairs of ... Sierra Leone,s needs for the next ...
    (Date:9/18/2014)... AMSTERDAM , September 18, 2014 ... in economic growth, and the situation is most likely to ... Atradius is observing an impact across all sectors in the ... a rise in inflation, limited access to external financing and ... could experience an increase in payment delays and ...
    (Date:9/18/2014)... VIEW, Calif. and CHESTERBROOK, Pa. ... (Nasdaq: VVUS ) and Auxilium Pharmaceuticals, Inc. ... U.S. Food and Drug Administration (FDA) has approved a supplemental ... is now the only FDA-approved erectile dysfunction (ED) medication indicated ... sexual activity. STENDRA is a prescription medication in ...
    Breaking Medicine Technology:World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 2World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 3World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 4Exporters to Russia Facing Increasing Payment Risk 2VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 2VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 3VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 4VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 5VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 6VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 7VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 8VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 9
    ... CHICAGO, Dec. 2 New research has found that the ... an emergency room can significantly increase the number of stroke ... study, conducted at North Shore Medical Center (NSMC)-Salem Hospital in ... of the Radiological Society of North America (RSNA). , ...
    ... an oral,presentation of preliminary results from a multi-center, US-based clinical,trial of TG101348 in myeloproliferative disease ... Details of the presentation are as follows:, Title: ... TG101348, an Orally Bioavailable, ... ...
    Cached Medicine Technology:Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3
    (Date:9/18/2014)... Los Angeles, CA (September 18, 2014) Cardiovascular disease ... high cholesterol plays a major role in accelerating ... as a treatment to decrease cholesterol-carrying lipoproteins such ... especially harmful. A new study, out today in ... finds that rosuvastatin may be more effective ...
    (Date:9/18/2014)... OR (PRWEB) September 18, 2014 Eye doctors ... hours can cause the all-important basal tear film in the ... recently reported in Salon.com* suggests that staring at a computer ... has been teaching her audience about computers, the tear film ... as an affirmation. , (*Gray, Sarah, “Staring at Screen ...
    (Date:9/18/2014)... Sutter Health’s California Pacific Medical Center (CPMC) ... by naming the Ray Dolby Brain Health Center in ... a founding gift of $21 million in 2011 to ... patients and families suffering from Alzheimer’s, dementia or other ... at the center since its opening in 2012. ...
    (Date:9/18/2014)... 18, 2014 Choosing the insulation for the ... a big deal to most homeowners, but Clean Crawls’ ... In their expert opinion, they explain why spray foam insulation ... care of their crawl space. , They highlight not ... but also its air tight seal and moisture protective abilities. ...
    (Date:9/18/2014)... Baltimore, MD (PRWEB) September 18, 2014 A ... body shaping system has been approved by the United States ... yet available for widespread purchase in the US, landmark dermatology ... first and only practices on the east coast to use ... the only practice in the Baltimore area to offer patients ...
    Breaking Medicine News(10 mins):Health News:New Study Confirms that Staring at a Computer Screen Alters Tear Film Content and Causes Dry Eye 2Health News:New Study Confirms that Staring at a Computer Screen Alters Tear Film Content and Causes Dry Eye 3Health News:Sutter Health’s CPMC announces Ray Dolby Brain Health Center 2Health News:Sutter Health’s CPMC announces Ray Dolby Brain Health Center 3Health News:Why Spray Foam Insulation is the Best Choice for Crawl Spaces Explained in Recent Article by Clean Crawls 2Health News:New FDA-Approved UltraShape Body Contouring Procedure Comes to Maryland Laser Skin and Vein 2
    ... Attributes proprietary database and technology for its 296 ... HTH Worldwide, a global health and,safety services company, ... for Greater Philadelphia, a ranking of the 50 ... in the,area by Deloitte LLP, one of the ...
    ... ANN ARBOR, Mich., Oct. 31 Terumo Heart ... System (LVAS) was,implanted in October at the University ... efforts toward an early application for approval,for manufacture ... the world,s first third generation left ventricular,assist system ...
    ... Oct. 31 Relaxation specialists,Lifehut.com, have released their ... "Finding Joy During Challenging Financial,Times.", Aimed at ... to allow people to enter an alpha state ... much going on in our economy, job layoffs ...
    ... its 5,000 Percent Revenue Growth from FY03-FY07 to Increased ... ... Accuray,Incorporated (Nasdaq: ARAY ), has been named to ... companies. This year,s Silicon Valley Technology Fast 50,program is co-presented ...
    ... Natural health news site,NaturalNews.com has teamed with ... omega-3 supplement to health-conscious consumers. Made,from green-lipped mussel ... of,New Zealand, Moxxor is a nutrient-rich marine omega-3 ... to enhance and support the,body,s healthy response to ...
    ... million (+30%y/y), EPS $0.23 (+44% y/y) - ... ... YORK, Oct. 31 HMS Holdings Corp. (Nasdaq:,HMSY) today announced its financial ... For the quarter ended September 30, 2008 revenue increased 30% to $49.0,million, ...
    Cached Medicine News:Health News:HTH Worldwide Ranked Number 21 in Deloitte's Fast 50 Program for Greater Philadelphia 2Health News:HTH Worldwide Ranked Number 21 in Deloitte's Fast 50 Program for Greater Philadelphia 3Health News:Lifehut.com Aims to Relax the Financially Stressed 2Health News:Accuray Incorporated Ranked Fifth in Deloitte's Technology Fast 50 Program for Silicon Valley Scientific/Medical Equipment, and Biotechnology Companies 2Health News:Accuray Incorporated Ranked Fifth in Deloitte's Technology Fast 50 Program for Silicon Valley Scientific/Medical Equipment, and Biotechnology Companies 3Health News:Accuray Incorporated Ranked Fifth in Deloitte's Technology Fast 50 Program for Silicon Valley Scientific/Medical Equipment, and Biotechnology Companies 4Health News:NaturalNews Partners with Moxxor to Bring Marine Omega-3 Supplement to Health-Conscious Consumers 2Health News:HMS Holdings Corp. Announces Q3 2008 Results, 2008 Revised Guidance and Initial 2009 Guidance 2Health News:HMS Holdings Corp. Announces Q3 2008 Results, 2008 Revised Guidance and Initial 2009 Guidance 3Health News:HMS Holdings Corp. Announces Q3 2008 Results, 2008 Revised Guidance and Initial 2009 Guidance 4Health News:HMS Holdings Corp. Announces Q3 2008 Results, 2008 Revised Guidance and Initial 2009 Guidance 5Health News:HMS Holdings Corp. Announces Q3 2008 Results, 2008 Revised Guidance and Initial 2009 Guidance 6Health News:HMS Holdings Corp. Announces Q3 2008 Results, 2008 Revised Guidance and Initial 2009 Guidance 7Health News:HMS Holdings Corp. Announces Q3 2008 Results, 2008 Revised Guidance and Initial 2009 Guidance 8Health News:HMS Holdings Corp. Announces Q3 2008 Results, 2008 Revised Guidance and Initial 2009 Guidance 9Health News:HMS Holdings Corp. Announces Q3 2008 Results, 2008 Revised Guidance and Initial 2009 Guidance 10
    Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
    Each handle is designed to fit a specific trephine size....
    Each handle is designed to fit a specific trephine size....
    Each handle is designed to fit a specific trephine size....
    Medicine Products: